P.2.f.028 Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial

Volume: 23, Pages: S411 - S412
Published: Oct 1, 2013
Abstract
Major depressive disorder (MDD) exerts a high health and financial burden on society. The conventional pharmacotherapies for MDD are partially effective and the response to medication often starts with some delay. There are recent reports of antidepressant effects for oral ketamine.We employed a double-blind controlled trial to examine the time course of the therapeutic effect of ketamine when combined with the conventional administration of...
Paper Details
Title
P.2.f.028 Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial
Published Date
Oct 1, 2013
Volume
23
Pages
S411 - S412
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.